1. Home
  2. SLP vs PROF Comparison

SLP vs PROF Comparison

Compare SLP & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simulations Plus Inc.

SLP

Simulations Plus Inc.

HOLD

Current Price

$14.80

Market Cap

250.6M

Sector

Technology

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.97

Market Cap

238.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLP
PROF
Founded
1996
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
250.6M
238.1M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
SLP
PROF
Price
$14.80
$6.97
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$24.00
$12.00
AVG Volume (30 Days)
371.2K
83.4K
Earning Date
04-09-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.89
EPS
0.26
1.41
Revenue
$59,577,000.00
$16,098,000.00
Revenue This Year
$3.80
$92.40
Revenue Next Year
$5.90
$64.10
P/E Ratio
$54.23
$4.83
Revenue Growth
10.52
50.73
52 Week Low
$11.09
$3.92
52 Week High
$34.01
$8.95

Technical Indicators

Market Signals
Indicator
SLP
PROF
Relative Strength Index (RSI) 60.38 56.97
Support Level $14.18 $5.75
Resistance Level $15.37 $7.07
Average True Range (ATR) 0.72 0.40
MACD -0.01 0.01
Stochastic Oscillator 67.16 74.07

Price Performance

Historical Comparison
SLP
PROF

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: